Magnus Björkholm
#138,369
Most Influential Person Now
Magnus Björkholm's AcademicInfluence.com Rankings
Magnus Björkholmphilosophy Degrees
Philosophy
#7097
World Rank
#10258
Historical Rank
Logic
#4175
World Rank
#5435
Historical Rank
Download Badge
Philosophy
Why Is Magnus Björkholm Influential?
(Suggest an Edit or Addition)Magnus Björkholm's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL). (2002) (542)
- Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. (2016) (512)
- ANTIBODIES TO CARDIOLIPIN IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION: AN ASSOCIATION WITH RECURRENT CARDIOVASCULAR EVENTS (1986) (382)
- Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells (2001) (337)
- Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients (2015) (325)
- Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. (2007) (306)
- Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. (2003) (281)
- INTERFERON THERAPY IN MYELOMATOSIS (1979) (276)
- Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells (2000) (272)
- Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. (2008) (235)
- Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells (2013) (227)
- Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms. (2011) (223)
- Risk of haematopoietic cancer in patients with inflammatory bowel disease (2005) (220)
- Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. (2011) (209)
- Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward (1995) (209)
- CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. (2003) (197)
- Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. (2009) (188)
- Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. (2012) (185)
- HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIA (1985) (175)
- Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. (2001) (170)
- Survival and cure of acute myeloid leukaemia in England, 1971‐2006: a population–based study (2013) (167)
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. (2008) (162)
- Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells (2008) (160)
- The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. (2010) (155)
- Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. (2008) (154)
- Frequent amplification of the telomerase reverse transcriptase gene in human tumors. (2000) (153)
- CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells (2008) (151)
- Autoimmunity and the risk of myeloproliferative neoplasms (2010) (144)
- Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin’s lymphomas among relatives of patients with chronic lymphocytic leukemia (2009) (140)
- Activation of telomerase by human cytomegalovirus. (2009) (134)
- Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. (2009) (131)
- Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003 (2007) (127)
- Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry. (2013) (120)
- The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. (2002) (120)
- Lymphocyte abnormalities in untreated patients with Hodgkin's disease (1976) (116)
- Determinants of Health-Related Quality of Life in Long-Term Survivors of Hodgkin's Lymphoma (2004) (113)
- Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study (2012) (109)
- FoxM1 is up‐regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kip1 (2009) (108)
- The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. (2007) (107)
- Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. (2013) (106)
- Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study. (2015) (104)
- Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. (2011) (103)
- Highly increased familial risks for specific lymphoma subtypes (2009) (103)
- Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden. (1994) (103)
- Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. (2003) (101)
- Modulation of anti‐idiotypic immune response by immunization with the autologous M‐component protein in multiple myeloma patients (1996) (99)
- Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics (2004) (99)
- Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. (2010) (99)
- Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years (2013) (98)
- Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. (2009) (96)
- Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. (2003) (96)
- Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study (2009) (94)
- The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma. (2015) (94)
- Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. (2010) (90)
- T cells in monoclonal gammopathies. (2009) (90)
- Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. (2006) (87)
- A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas. (2004) (87)
- Cancer risk among patients with myotonic muscular dystrophy. (2011) (86)
- Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders. (2004) (84)
- Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping (2004) (83)
- The incidence of cancer among blood donors. (1990) (83)
- Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma (2000) (81)
- Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study. (2016) (81)
- Natural killer cell activity in monoclonal gammopathies: Relation to disease activity (1990) (81)
- Prognostic factors in hodgkin's disease with special reference to age (1984) (80)
- Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms (1999) (79)
- Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings. (1983) (78)
- Individual quality of life in long-term survivors of Hodgkin's lymphoma – a comparative study (2003) (78)
- Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009. (2012) (77)
- Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome. (2003) (77)
- Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications. (1984) (76)
- Patterns of hematologic malignancies and solid tumors among 37,838 first‐degree relatives of 13,896 patients with multiple myeloma in Sweden (2009) (75)
- Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973–2003 in Sweden (2009) (75)
- Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. (2000) (75)
- The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. (2006) (72)
- Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. (2011) (72)
- Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study (2018) (72)
- A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. (2005) (72)
- Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia-A Systematic Review With Meta-analysis. (2018) (71)
- Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden. (1984) (70)
- Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. (2004) (70)
- Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden (1993) (68)
- Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation – a prospective study (1997) (68)
- A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma (2004) (67)
- High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma. (2005) (66)
- Thrombosis is associated with inferior survival in multiple myeloma (2012) (65)
- A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies (2004) (63)
- Mitogen-Activated Protein Kinase Cascade-Mediated Histone H3 Phosphorylation Is Critical for Telomerase Reverse Transcriptase Expression/Telomerase Activation Induced by Proliferation (2006) (62)
- Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients (2018) (62)
- Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. (2003) (62)
- TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas (2014) (62)
- Differential Expression of Full-length Telomerase Reverse Transcriptase mRNA and Telomerase Activity between Normal and Malignant Renal Tissues (2005) (62)
- Patterns of survival in lymphoplasmacytic lymphoma/waldenström macroglobulinemia: A population‐based study of 1,555 patients diagnosed in Sweden from 1980 to 2005 (2013) (62)
- Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia. (1992) (61)
- Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity? (2002) (61)
- Interleukin‐10 gene promoter polymorphisms in multiple myeloma (2001) (60)
- Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage. (1996) (60)
- Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in sweden. (2009) (60)
- Chromatin remodeling: recruitment of histone demethylase RBP2 by Madl for transcriptional repression of a Myc target gene, telomerase reverse transcriptase (2010) (59)
- Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection (2012) (58)
- AMPLIFICATION OF THE C‐MYC ONCOGENE IN HUMAN PLASMA‐CELL LEUKEMIA (1985) (58)
- Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone. (1982) (58)
- Telomere dysfunction induced by chemotherapeutic agents and radiation in normal human cells. (2012) (57)
- Telomerase activity in plasma cell dyscrasias (2000) (57)
- TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR (2014) (57)
- Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease. (2000) (56)
- Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix (2004) (55)
- The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy. (2006) (54)
- Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas (2002) (54)
- High‐dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia (2002) (54)
- Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life (2016) (53)
- Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era (2015) (53)
- Patients’ perceptions of having a central venous catheter or a totally implantable subcutaneous port system–results from a randomised study in acute leukaemia (2009) (53)
- T‐Cell Stimulation Induced by Idiotypes on Monoclonal Immunoglobulins in Patients with Monoclonal Gammopathies (1993) (52)
- Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up. (2007) (51)
- Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma. (2019) (51)
- Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells. (2004) (50)
- Intermittent melphalan and prednisolone therapy in plasma cell myeloma. (2009) (50)
- A population‐based assessment of mortality and morbidity patterns among patients with thymoma (2011) (50)
- Reptin is required for the transcription of telomerase reverse transcriptase and over-expressed in gastric cancer (2010) (50)
- Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia—a randomized study (2004) (50)
- Increased remissions from one course for intermediate‐dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population‐based phase II study (2003) (49)
- Therapeutic effects of low‐dose cytosine arabinoside, alpha‐interferon, 1α‐hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes (1988) (49)
- Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study. (2003) (49)
- Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model. (2012) (49)
- Epstein–Barr virus expression in Hodgkin’s disease in relation to patient characteristics, serum factors and blood lymphocyte function (1999) (48)
- 15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells. (2009) (48)
- Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication (2007) (48)
- Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia (2002) (47)
- Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated? (2014) (46)
- Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL (2001) (46)
- Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. (2000) (46)
- Change of central venous catheter dressings twice a week is superior to once a week in patients with haematological malignancies. (1995) (44)
- Multidrug resistance in relapsed acute myeloid leukemia: Evidence of biological heterogeneity (2013) (44)
- Molecular cytogenetic characterization of acute myeloid leukemia and myelodysplastic syndromes with multiple chromosome rearrangements. (2001) (44)
- Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden. (1993) (43)
- Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy (1993) (43)
- Successful intravenous immunoglobulin therapy for severe and persistent astrovirus gastroenteritis after fludarabine treatment in a patient with Waldenström's macroglobulinemia. (1995) (43)
- Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III —A randomized study from MGCS (1989) (43)
- Hematological: Low all‐cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single‐center study (2012) (43)
- Interleukin‐10 mRNA expression in B‐cell chronic lymphocytic leukaemia inversely correlates with progression of disease (1996) (42)
- Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument (2008) (41)
- Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma. (2018) (41)
- RT‐PCR analysis of the MOZ‐CBP and CBP‐MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13) (2000) (40)
- Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect. (2009) (40)
- On the expression of cytosolic calcium‐independent phospholipase A2 (88 kDa) in immature and mature myeloid cells and its role in leukotriene synthesis in human granulocytes (1998) (40)
- Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia. (2006) (39)
- A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia. (2003) (39)
- Do steroids increase lymphoma risk? A case–control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis (2005) (39)
- The Opposing Effect of Hypoxia-Inducible Factor-2α on Expression of Telomerase Reverse Transcriptase (2007) (39)
- Tissue Eosinophilia in Relation to Immunopathological and Clinical Characteristics in Hodgkin's Disease (2001) (38)
- Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis. (1982) (38)
- Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. A prospective randomized trial. (1995) (38)
- Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3 Lysine 4 Methylation/Demethylation (2012) (38)
- Long‐term survival in young and middle‐aged Hodgkin lymphoma patients in Sweden 1992–2009—trends in cure proportions by clinical characteristics (2015) (37)
- No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease (2003) (36)
- Clonal cell surface structures related to differentiation, activation and homing in B‐cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance (1989) (36)
- Autoimmunity and risk for Hodgkin’s lymphoma by subtype (2009) (34)
- Blood and lymph node T-lymphocyte subsets in non-Hodgkin lymphomas. (2009) (34)
- Persisting lymphocyte deficiences during remission in Hodgkin's disease. (1977) (34)
- Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. (2012) (34)
- Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy. (2009) (33)
- Septicemia in patients with hematological disorders and neutropenia. A retrospective study of causative agents and their resistance profile. (1991) (33)
- Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS). (1989) (33)
- Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis (2005) (33)
- Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens. (1984) (33)
- Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies (2009) (33)
- Hodgkin Reed–Sternberg cells express 15‐lipoxygenase‐1 and are putative producers of eoxins in vivo (2008) (33)
- Immune status of untreated patients with Hodgkin's disease and prognosis. (1982) (33)
- Lysine-Specific Demethylase 1 (LSD1) Is Required for the Transcriptional Repression of the Telomerase Reverse Transcriptase (hTERT) Gene (2008) (33)
- Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes. (2004) (31)
- Granulocyte‐macrophage colony‐stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial (2004) (31)
- The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression (2015) (30)
- Blood T-lymphocyte functions in healthy adults in relation to age. (2009) (30)
- Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long‐term follow‐up (1991) (30)
- Three-dimensional culturing of the Hodgkin lymphoma cell-line L1236 induces a HL tissue-like gene expression pattern (2007) (29)
- High expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes (2009) (29)
- Immunodeficiency in Hodgkin's disease and its relation to prognosis. (1978) (29)
- Blood clonal B‐cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation (1996) (29)
- Immunological defects in healthy twin siblings to patients with Hodgkin's disease. (2009) (29)
- Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis. (2020) (28)
- How we treat elderly patients with Hodgkin lymphoma (2011) (28)
- Mitoxantrone, etoposide and cytarabine in the treatment of acute nonlymphocytic leukemia. (1990) (28)
- A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease (1990) (28)
- Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia. (2009) (28)
- Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation. (1999) (28)
- Population‐based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence (2016) (28)
- Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells (2017) (28)
- Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006). (2013) (28)
- Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture. (1975) (27)
- Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection (2013) (27)
- TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations (2016) (27)
- Caspase-3-dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells. (2016) (27)
- Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma. (1983) (27)
- Risk of infections in patients with myeloproliferative neoplasms—a population-based cohort study of 8363 patients (2020) (27)
- An EBV genome carrying pre-B cell leukemia in a homosexual man with characteristic karyotype and impaired EBV-specific immunity. (1986) (26)
- Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA. (2007) (26)
- Validation of an Extended Version of the SEIQoL-DW in a Cohort of Hodgkin Lymphoma’ Survivors (2005) (26)
- Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma. (2016) (26)
- Assessing nursing students' knowledge and skills in performing venepuncture and inserting peripheral venous catheters. (2017) (26)
- Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973–2001, a population‐based study (2010) (26)
- Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues. (2008) (26)
- Intensive treatment in order to minimize the ph‐positive clone in chronic myelogenic leukemia (1993) (25)
- Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models (2012) (25)
- Timing of births and endometrial cancer risk in Swedish women (2009) (25)
- Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma (2009) (25)
- Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells (2015) (25)
- Immunological and hematological abnormalities in chronic alcoholism. (2009) (25)
- Post-splenectomy septicemia in Hodgkin's disease and other disorders. (1980) (24)
- Intravenous immunoglobulin treatment in cytopenic haematological disorders (1993) (24)
- No familial aggregation in chronic myeloid leukemia. (2013) (24)
- Late seroconversion and high chronicity rate of hepatitis C virus infection in patients with hematologic disorders. (1993) (24)
- LMP-1, the Epstein-Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40. (1999) (24)
- CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: a randomized clinical trial. (1985) (24)
- Intensive Treatment and Stem Cell Transplantation in Chronic Myelogenous Leukemia: Long-Term Follow-Up (2005) (24)
- Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura (2006) (23)
- Mitoxantrone, etoposide and ara‐C vs doxorubicin‐DNA, ara‐C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparison (1995) (23)
- Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins. (2001) (23)
- Treatment of multiple myeloma with interferon alpha: the Scandinavian experience (1991) (23)
- Alpha interferon treatment of patients with hairy-cell leukaemia. (2009) (23)
- Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers. (1981) (23)
- Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma. (2004) (23)
- Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival. (2015) (23)
- Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects (2013) (23)
- Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib (2015) (23)
- Incidence of myeloproliferative neoplasms – trends by subgroup and age in a population‐based study in Sweden (2020) (22)
- The expression of cytosolic phospholipase A2 and biosynthesis of leukotriene B4 in acute myeloid leukemia cells (2007) (22)
- Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study (2016) (22)
- Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up (2013) (22)
- A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia. (1991) (22)
- Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase – a report from the Swedish CML Group (2002) (22)
- Surface immunoglobulin pattern of the leukaemic cell population in chronic lymphocytic leukaemia (CLL) in relation to disease activity (1985) (22)
- Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience (2005) (21)
- A method to visualize and adjust for selection bias in prevalent cohort studies. (2011) (21)
- Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma (2014) (21)
- Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia. (2001) (21)
- ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells (2019) (21)
- Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis (2013) (21)
- Immunological family studies in Hodgkin's disease. Is the immunodeficiency horizontally transmitted? (2009) (20)
- Fractures and survival in multiple myeloma: results from a population-based study (2019) (20)
- Outpatient parenteral antibiotic therapy in patients with haematological malignancies (2001) (20)
- Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial? (2005) (20)
- Familial Aggregation of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia with Solid Tumors and Myeloid Malignancies (2012) (20)
- Macrophage association of polyomavirus in progressive multifocal leukoencephalopathy: an immunohistochemical and ultrastructural study (1992) (20)
- Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders. (1992) (20)
- Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (2014) (19)
- Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma—A population‐based study from Sweden (2018) (19)
- History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study (2016) (19)
- Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance (2009) (19)
- Dendritic Cells in Bone Marrow at Diagnosis and after Chemotherapy in Adult Patients with Acute Myeloid Leukaemia (2014) (19)
- Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group. (1996) (19)
- Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia (2009) (19)
- Cyclic autoimmune hemolytic anemia as a presenting manifestation of splenic Hodgkin's disease (1982) (19)
- The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population (2016) (19)
- Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial. (1980) (19)
- Tackling Two Diseases with HDL (2010) (18)
- Type‐specific anti‐pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients (1989) (18)
- Histone Chaperone ASF1A Predicts Poor Outcomes for Patients With Gastrointestinal Cancer and Drives Cancer Progression by Stimulating Transcription of β-Catenin Target Genes (2017) (18)
- The absence of TERT promoter mutations in primary gastric cancer. (2014) (18)
- A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease. (2008) (18)
- Long‐term follow‐up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapy (2002) (18)
- Evidence for a pathophysiological role of cysteinyl leukotrienes in classical Hodgkin lymphoma (2008) (18)
- S-phase lymphocytes in chronic lymphocytic leukemia (CLL) in relation to immunoglobulin isotypes on the leukemic clone and to disease activity. (1987) (18)
- Interleukin-4-Mediated 15-Lipoxygenase-1 Trans-Activation Requires UTX Recruitment and H3K27me3 Demethylation at the Promoter in A549 Cells (2014) (18)
- Premature senescence of T cells in long-term survivors of renal transplantation. (2011) (17)
- Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease. (2009) (17)
- Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line. (2012) (17)
- Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance. (2011) (17)
- Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013 (2016) (17)
- T lymphocyte subpopulations in chronic lymphocytic leukemia of B cell type in relation to immunoglobulin isotype(s) on the leukemic clone and to clinical features (1987) (17)
- Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden (2012) (17)
- Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes (2015) (17)
- Cefepime as empirical monotherapy in febrile patients with hematological malignancies and neutropenia: a randomized, single-center phase II trial. (1999) (17)
- Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support. (1996) (17)
- Anti‐Idiotypic B Lymphocytes in Patients with Monoclonal Gammopathies (1994) (17)
- Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies (2004) (17)
- Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia. (2009) (16)
- Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma (2008) (16)
- Survival patterns among lymphoma patients with a family history of lymphoma. (2008) (16)
- Personal and family history of autoimmune diabetes mellitus and susceptibility to young‐adult‐onset Hodgkin lymphoma (2006) (16)
- Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease. (2010) (16)
- Immunodeficiency and prognosis in Hodgkin's disease. (2009) (16)
- A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells. (1994) (16)
- Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy (2014) (16)
- Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia (2015) (16)
- T-Lymphocyte deficiency following adult thymectomin man. (2009) (16)
- Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells (2011) (15)
- Successful pregnancy in a 28-year-old patient autografted for acute lymphoblastic leukemia following myeloablative treatment including total body irradiation. (1993) (15)
- Increased serum CD8 soluble antigen level is associated with blood lymphocyte abnormalities and other established indicators of a poor prognosis in adult Hodgkin's disease (1992) (15)
- Tumour imaging of indium‐111 oxine‐labelled autologous lymphocytes as a staging method in Hodgkin's disease (1989) (15)
- No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy (2020) (15)
- Epidemiological study of Hodgkin's disease in Cuba and Sweden. (1990) (15)
- Increase of monocytes predicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G‐CSF administration (1995) (14)
- Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population‐based cohort study in Sweden and Norway (2019) (14)
- Blood lymphocyte characteristics as predictors of prognosis in chronic lymphocytic leukemia of B‐cell type (1988) (14)
- Infections in neutropenic patients I: Aetiology (1995) (14)
- Risk of Arterial and Venous Thrombosis in 11,155 Patients with Myeloproliferative Neoplasms and 44,620 Matched Controls; A Population-Based Study (2014) (14)
- Monocyte function in Hodgkin's disease. (1982) (14)
- Myocardial rupture with cardiac tamponade as a lethal early manifestation of acute myeloblastic leukemia (1982) (14)
- Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia. (2013) (13)
- A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients. (2006) (13)
- Human 15‐lipoxygenase‐1 is a regulator of dendriticcell spreading and podosome formation (2017) (13)
- The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study. (2016) (13)
- The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients (2016) (13)
- Hodgkin lymphoma risk following infectious and chronic inflammatory diseases: a large population-based case–control study from Sweden (2015) (13)
- Loss in life expectancy and gain in life years as measures of cancer impact. (2019) (13)
- Etoposide and teniposide in the treatment of acute leukemia (1990) (13)
- Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study (2016) (13)
- In vivo accumulation of etoposide in peripheral leukemic cells in patients treated for acute myeloblastic leukemia; relation to plasma concentrations and protein binding. (1993) (12)
- Increased blood clearance rate of indium-111 oxine-labeled autologous CD4+ blood cells in untreated patients with Hodgkin's disease. (1990) (12)
- Stimulation of T-cell cytokine production and NK-cell function by IL-2, IFN-alpha and histamine treatment during remission of non-Hodgkin's lymphoma. (2003) (12)
- Immunosuppressive serum factors and lymphocyte deficiency in Hodgkin's disease. (1979) (12)
- (D)-penicillamine treatment in systemic sclerosis (scleroderma). Effect on nutritional capillary circulation. (1977) (12)
- Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators. (2018) (12)
- Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation (1991) (12)
- Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern (1997) (12)
- Brain tumors in patients with myotonic dystrophy: a population‐based study (2016) (12)
- High serum vascular endothelial growth factor level is an adverse prognostic factor for high‐risk diffuse large B‐cell lymphoma patients treated with dose‐dense chemoimmunotherapy (2012) (12)
- Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients (2010) (11)
- Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas. (2008) (11)
- Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non‐Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHL (1991) (11)
- Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment? (2006) (11)
- Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236. (2010) (11)
- Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice. (1996) (11)
- Expression patterns of CD33 and CD15 predict outcome in patients with acute myeloid leukemia (2008) (11)
- Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma. (1998) (11)
- Severe aplastic anemia associated with seronegative community-acquired hepatitis C virus infection (1993) (11)
- Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma. (2021) (11)
- Aplastic anaemia: pathogenetic mechanisms and treatment with special reference to immunomodulation (1992) (10)
- Etoposide, doxorubicin, cyclophosphamide and high‐dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myeloma (1993) (10)
- Pharmacokinetics of mitoxantrone, etoposide and cytosine arabinoside in leukemic cells during treatment of acute myelogenous leukemia--relationship to treatment outcome and bone marrow toxicity. (1995) (10)
- Prolonged remission induced by interferon-α in a patient with refractory T-cell ALL (1990) (10)
- Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting. (1987) (10)
- EBV Infection Induces Expression of the Transcription Factors ATF-2/c-Jun in B Lymphocytes but not in B-CLL Cells (2005) (10)
- The Application of Cure Models in the Presence of Competing Risks: A Tool for Improved Risk Communication in Population-Based Cancer Patient Survival (2014) (10)
- An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma (2019) (10)
- Monitoring of hearing during treatment of leukaemia with special reference to the use of amikacin (1993) (10)
- Regulatory region mutations of TERT, PLEKHS1 and GPR126 genes as urinary biomarkers in upper tract urothelial carcinomas (2021) (10)
- Chemoprophylaxis of fungal infections in neutropenic patients. (1994) (10)
- High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS). (1988) (9)
- Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin'S disease (1982) (9)
- Prognostic influence of early diagnostic splenectomy in Hodgkin's disease. A long-term follow-up. (2009) (9)
- Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease (2000) (9)
- Oral etoposide in patients with hematological malignancies: a clinical and pharmacokinetic study. (2001) (9)
- Phase II study of cyclophosphamide, interferon-alpha and betamethasone (CIB) as induction therapy for patients 60-75 years of age with multiple myeloma stages II and III. (2003) (9)
- Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms (2009) (9)
- Disseminated Mycobacterium malmoense infection in a patient with chronic granulocytic leukaemia (1993) (9)
- Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1. (2013) (9)
- The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma. (2019) (9)
- Oral etoposide in patients with hematological malignancies (2001) (9)
- CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis). (2008) (9)
- Connective tissue growth factor is expressed in malignant cells of Hodgkin lymphoma but not in other mature B-cell lymphomas. (2010) (9)
- Blood donation and risk of polycythemia vera (2016) (9)
- Infection in infancy and subsequent risk of developing lymphoma in children and young adults. (2011) (9)
- Pharmacokinetics of Mitoxantrone in Plasma and Leukemic Cells During Treatment of Patients with Acute Non-Lymphocytic Leukemia (1992) (9)
- Increased Risk of Cardiovascular Events Associated with TKI Treatment in Chronic Phase Chronic Myeloid Leukemia : Data from Swedish Population-Based Registries (2014) (9)
- Haematologic effects of granulocyte‐macrophage colony stimulating factor in a patient with thiamazole‐induced agranulocytosis (1992) (9)
- Infections in neutropenic patients II: Management (1996) (9)
- Parental longevity and survival in elderly patients with Hodgkin's lymphoma. (2002) (9)
- Spontaneously DNA synthesizing blood and spleen lymphocytes in Hodgkin's disease. (2009) (9)
- Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia. (1999) (8)
- Comorbidities in multiple myeloma and implications on survival: A population‐based study (2021) (8)
- GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma (2022) (8)
- On the size and tumor involvement of the spleen in Hodgkin's disease. (2009) (8)
- Parental longevity and prognosis in elderly patients with aggressive non-hodgkin's lymphoma (2004) (8)
- Blood lymphocyte functions in relation to splenic weight and tumor involvement in untreated Hodgkin's disease. (2009) (8)
- Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen. (1983) (8)
- The telomerase gene polymorphisms, but not telomere length, increase susceptibility to primary glomerulonephritis/end stage renal diseases in females (2020) (8)
- Dysregulation of shelterin factors coupled with telomere shortening in Philadelphia chromosome negative myeloproliferative neoplasms (2015) (8)
- Survival in patients with familial and sporadic myeloproliferative neoplasms. (2015) (8)
- Promoter Polymorphism in the Serotonin Transporter (5-HTT) Gene Is Significantly Associated with Leukocyte Telomere Length in Han Chinese (2014) (8)
- Epstein‐Barr virus‐associated antibody pattern in untreated non‐Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions (1983) (8)
- [Pine processionary moth--a big health problem in southern Gotland. Results of a questionnaire study]. (2009) (8)
- Effect of verapamil on daunorubicin accumulation in human leukemic cells with different levels of MDR1 gene expression. (1993) (8)
- Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia (2004) (8)
- Correction to: MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia (2018) (8)
- Skin capillary abnormalities in patients with Raynaud's phenomenon. (2009) (8)
- Antibody reactivities to skeletal muscle proteins in a patient with λ light chain secreting multiple myeloma, generalised amyloidosis and rhabdomyolysis (2001) (8)
- Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: A preliminary report (2004) (7)
- Phase II study of subcutaneous alemtuzumab (Campath-1H) therapy of patients with previously untreated chronic lymphocytic leukemia (CLL). (2001) (7)
- Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden (2014) (7)
- Suicide in multiple myeloma and acute myeloid leukaemia. (2007) (7)
- Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy. (1995) (7)
- Self-reported fertility in long-term survivors of acute myeloid leukemia (2014) (7)
- Adjuvant immunotherapy in acute nonlymphocytic leukemia (1978) (7)
- Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival. (2004) (7)
- Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-group. (1994) (7)
- Low incidence of candidaemia among neutropenic patients treated for haematological diseases. (1998) (7)
- Increased luminol‐enhanced chemiluminescence of blood monocytes and granulocytes in Hodgkin's disease (1991) (7)
- Kinetic measurement of the erythrocyte sedimentation rate. (1994) (7)
- Blood clonal B cell excess (CBE) at diagnosis in patients with non-Hodgkin lymphoma (NHL). Relation to clinical stage, histopathology and response to treatment. (1987) (7)
- Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia (2012) (7)
- Phosphorylation of serine 523 on 5-lipoxygenase in human B lymphocytes. (2015) (6)
- Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls. (2020) (6)
- Leukotriene B 4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells (2004) (6)
- Studies of the Organ Distribution in Mice of Teniposide Liposomes Designed for Treatment of Diseases in the Mononuclear Phagocytic System (1995) (6)
- Early growth response gene (EGR)-1 regulates leukotriene D4-induced cytokine transcription in Hodgkin lymphoma cells. (2015) (6)
- Cytotoxic activity of lymphocytes from patients with Hodgkin's disease. (1975) (6)
- Cancer survivorship programs: time for concerted action (2014) (6)
- Essential thrombocythaemia and polycythaemia vera presenting with pulmonary embolism mimicing pneumonia. Case reports. (1981) (6)
- Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era (2014) (6)
- No additional toxicity from cladribine (CdA) when given with cytosin arabinoside and idarubicin (CCI) as primary treatment of acute myeloid leukemia in elderly patients : Results from a randomized phase II-study from the leukemia group of middle Sweden (LGMS). (2001) (6)
- TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders (2008) (6)
- Longitudinal studies of blood lymphocyte functions in non-Hodgkin's lymphoma. (1983) (6)
- Hyperleukocytic effects on skin capillary circulation in patients with leukaemia (1992) (6)
- Caesarean section in previously untreated acute promyelocytic leukaemia. Report of two patients. (2000) (6)
- FAMILIAL LONGEVITY: THE OLDER YOU ARE, THE OLDER YOUR FATHER MAY HAVE BEEN (2005) (6)
- Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease. (1985) (6)
- Genomic analysis of the clonal origin and evolution of acute promyelocytic leukemia in a unique patient with a very late (17 years) relapse (2014) (6)
- Membrane bound IgG on erythroblasts in pure red cell aplasia following thymectomy. A case report. (2009) (6)
- Antibody-dependent haemolytic activity of human leukaemic cells. (1980) (6)
- Higher in vivo protein binding of etoposide in children compared with adult cancer patients. (1996) (6)
- Increased Risks of Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Myelofibrosis (MF) among 24577 First-Degree Relatives of 11039 Patients with Chronic Myeloproliferative Disorders (MPD) in Sweden. (2007) (6)
- Granulocyte function in elderly patients receiving chemotherapy for aggressive non-Hodgkin's lymphoma. Effect of granulocyte colony-stimulating factor. (2002) (5)
- Bone Marrow Fibrosis In Patients With Multiple Myeloma: A New Prognostic Factor For Survival? (2013) (5)
- Multiple Myeloma and Infections: A Population-Based Study Based On 9,610 Multiple Myeloma Patients (2012) (5)
- Simultaneously presenting aplastic anaemia and Hodgkin's disease successfully treated with allogeneic bone marrow transplantation (1991) (5)
- Extensive nodular infiltration of extra-osseous tissues in human myelomatosis. A case report. (2009) (5)
- Functional aspects on the Klippel-Trénaunay and related syndromes. (1980) (5)
- patients: a population-based study in Sweden lymphoplasmacytic lymphoma/Waldenström macroglobulinemia Risk of lymphoproliferative disorders among first-degree relatives of (2013) (5)
- Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial) (2016) (5)
- Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study (2016) (5)
- Reproducibility of tumor response evaluation in patients with high-grade malignant non-hodgkin’s lymphoma (2001) (5)
- Temporary arterio-venous shunts to dilate saphenous crossover graft and maintain graft patency. (1976) (5)
- IFN-gamma is not the only mediator of suppressed myelopoiesis produced by mononuclear cells from aplastic anemia patients. (1987) (5)
- Abstract 8: Reptin is required for the transcription of telomerase reverse transcriptase and overexpressed in gastric cancer (2010) (5)
- Improved patient survival for acute myeloid leukemia: A population-based study of 9,729 patients diagnosed in Sweden 1973-2005 Running title: Survival in acute myeloid leukemia (2008) (5)
- Treatment options in Waldenstrom's macroglobulinemia. (2004) (5)
- Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia? (2009) (5)
- Clonal blood B-cell excess in relation to prognosis in untreated non-leukemic patients With non-Hodgkin’s lymphoma (NHL) (1985) (5)
- The 5-lipoxygenase pathway in normal and malignant human B lymphocytes. (1995) (5)
- JAK2 inhibition in JAK2V617F-bearing leukemia cells enriches CD34+ leukemic stem cells that are abolished by the telomerase inhibitor GRN163L. (2020) (5)
- Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'-oligoadenylate synthetase in the liver and peripheral blood cells. (1996) (5)
- Differing effects of estradiol on erythroid cells in the bone marrow and spleen of guinea pigs. (1974) (4)
- Disease anticipation in familial myeloproliferative neoplasms. Authors' reply (2008) (4)
- Expression of the signal transduction molecule ζ in peripheral and tumour‐associated lymphocytes in Hodgkin's disease in relation to the Epstein–Barr virus status of the tumour cells (2002) (4)
- Clinical findings and prognostic factors in chronic myeloid leukemias. (2009) (4)
- Late infections after blood progenitor cell transplantation in patients with multiple myeloma. (2001) (4)
- Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance (2020) (4)
- Immunodeficiency and prognosis in patients with non-Hodgkin's lymphomas. (1985) (4)
- Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma (2021) (4)
- Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central Sweden. (1990) (4)
- Molecular Cytogenetic Approach to the Diagnosis of Splenic Lymphoma: A Case Report of Blastoid Mantle Cell Lymphoma (2003) (4)
- Disseminated tuberculosis treated with amikacin in a patient with acute myelocytic leukemia. (1997) (4)
- The measurement of venous haematocrit in patients with polycythaemia vera (1999) (4)
- Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls (2019) (4)
- No effect of delayed cutaneous hypersensitivity testing (Multitest) on blood lymphocyte counts and functions. (2009) (4)
- Fludarabine and plasma cell leukemia (1995) (4)
- Temporal trends in treatment‐related incidence of diseases of the circulatory system among Hodgkin lymphoma patients (2019) (4)
- Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008 (2010) (4)
- Chapter 20 – Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia (2006) (4)
- Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase (2006) (4)
- The Success Story of Targeted Therapy In Chronic Myeloid Leukemia A Population Based Study of 3,173 Patients Diagnosed In Sweden 1973-2008 (2010) (4)
- Melphalan/prednisone versus melphalan/prednisone plus human alpha interferon therapy in patients with multiple myeloma, stages II and III. Myeloma Group of Central Sweden. (1991) (4)
- Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet! (2016) (4)
- Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients. (1996) (4)
- Myeloblative therapy with autologous haematopoietic stem cell support as consolidation of first remission in acute myeloid leukaemia – very long follow‐up (2014) (4)
- Antipyretic effect of indomethacin in malignant lymphoma. (2009) (4)
- Detailed characterization of a complex karyotype in a patient with primary plasma cell leukaemia using multicolour spectral karyotyping and micro-FISH. (2000) (4)
- Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg) (1985) (4)
- A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre‐ibrutinib era (2020) (3)
- Setae from Larvae of the Northern Processionary Moth (Thaumetopoea pinivora, TP) Stimulate Proliferation of Human Blood Lymphocytes In Vitro (2014) (3)
- Temporal Trends in Chronic Myeloid Leukemia Outcome Using the Loss in Expectation of Life: A Swedish Population-Based Study (2015) (3)
- Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls (2017) (3)
- Clinical and laboratory findings in untreated patients with Hodgkin’s disease with special reference to age (1984) (3)
- Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms—a nationwide population-based study of 342 pregnancies in Sweden (2022) (3)
- DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML). (1992) (3)
- High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B Cell Lymphoma (DLBCL) Patients Treated with Dose Dense Chemoimmunotherapy and Systemic CNS Prophylaxis Results From a Nordic Phase II Study (2010) (3)
- Optimizing investigator-led oncology research in Europe (2012) (3)
- No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden (2017) (3)
- Deep vein thrombosis following monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (2008) (3)
- Elevated Risk of Venous but Not Arterial Thrombosis in Waldenström's Macroglobulinemia and Lymphoplasmacytic Lymphoma (2012) (3)
- No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study (2015) (3)
- Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells. (2021) (3)
- Family history of venous thromboembolism is associated with increased risk for thrombosis in multiple myeloma: a population‐based study (2012) (3)
- Mitogen induced blood lymphocyte DNA synthesis as a prognostic indicator in patients with non-Hodgkin's lymphomas in clinical remission. (1983) (3)
- Immunologic evaluation of patients with ischemic heart disease. Genetic determination and relation to disease. (1980) (3)
- V-region-specific alterations of serum IgM production in multiple myeloma of IgG class. (2000) (3)
- A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biological effects, and impact on quality of life (2006) (3)
- Mitoxantrone, Etoposide and Cytarabine in the Treatment of Acute Myelocytic Leukemia (AML) (1994) (3)
- CNOP (Mitoxantrone) Chemotherapy Is Inferior to CHOP (Doxorubicin) in the Treatment of Patients with Aggressive Non-Hodgkin Lymphoma (Review). (2006) (3)
- Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population‐based cohort study (2021) (2)
- Genetics in Lymphomagenesis (2013) (2)
- Gene Expression Analyses At Time Of Diagnosis Indicate Biomarkers Predictive Of Therapeutic Response In Acute Myeloid Leukemia (2013) (2)
- Dose-Dense Chemoimmunotherapy and Early Central Nervous System Prophylaxis For High-Risk Diffuse Large B-Cell Lymphoma. –Preliminary Results From a Nordic Phase II Study (2013) (2)
- A Phase II Trial of Pegylated Interferon α-2b in Polycythemia Vera and Essential Thrombocythemia. Clinical Responses, Effects on PRV-1 Expression and Impact on Quality of Life. (2004) (2)
- Use of a novel measuring technique for the erythrocyte sedimentation rate--a pilot study in patients with neutropenia and fever. (1994) (2)
- Prognosis in Acute Myeloid Leukemia: A Population-Based Study on 5,809 Patients Diagnosed in Sweden 1973–2001. (2005) (2)
- Trends in survival of young adult patients with acute lymphoblastic leukemia in Sweden and USA. (2019) (2)
- Routine laboratory tests in relation to spleen size and tumour involvement in untreated Hodgkin's disease. (2009) (2)
- No evidence of a lymphocytopenic state before manifestation of chronic lymphocytic leukemia. (2009) (2)
- Prognostic significance of immunoglobulin isotype expression in B-cell non-Hodgkin’s lymphoma (1988) (2)
- Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia (2004) (2)
- PS1463 SURVIVAL OUTCOMES IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB: A POPULATION-BASED COHORT STUDY IN SWEDEN AND NORWAY (2019) (2)
- Increased Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Lymphoproliferative Tumors among 14689 First-Degree Relatives of 4488 MGUS Patients in Sweden. (2007) (2)
- Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study (2016) (2)
- Leucocyte doubling time is a useful predictor of progression‐free survival in chronic lymphocytic leukaemia (1995) (2)
- Quantitative investigation of stem cell candidates in the bone marrow of growing guinea pigs. (1975) (2)
- Daunorubicin versus aclarubicin in combination with cytarabine and thioguanine in elderly patients with acute nonlymphocytic leukemia, a preliminary report (1987) (2)
- Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study (2014) (2)
- Real-word data on autologous stem cell transplantation in older patients with multiple myeloma (2019) (2)
- A Population-Based Study of Incidence of Myeloproliferative Neoplasms in Sweden Between 2000 and 2012 (2015) (2)
- Advances in Brief Molecular Characterization of Human Telomerase Reverse Transcriptase-immortalized Human Fibroblasts by Gene Expression Profiling : Activation of the Epiregulin Gene 1 , 2 (2003) (1)
- [Acute myeloid leukemia. Achievements and challenges in the treatment of adults]. (1997) (1)
- [Mycotic infections in neutropenic patients. Necessary with adequate prevention]. (1994) (1)
- Hemodynamic influence of multiple congenital arteriovenous fistulas. Report of a case. (2009) (1)
- Dose-Dense Chemoimmunotherapy and Early CNS Prophylaxis for High-Risk DLBCL.: Interim Results from a Nordic Phase II Study (2015) (1)
- [Prophylactic and empirical treatment of mycoses in neutropenic fever. Report and comments on meta-analysis]. (2001) (1)
- INTERFERON THERAPY IN MYELOMATOSIS (1979) (1)
- Improved Patient Survival and Cure for Hodgkin Lymphoma: A Population-Based Study of 6,136 Patients Diagnosed in Sweden 1973-2005. (2009) (1)
- Delayed skin hypersensitivity in man. The effect of repeated tests with low-dose antigen. (1988) (1)
- Inhibition of signal transducer and activator of transcription 6 activity in the Hodgkin lymphoma cell line L1236 induces growth inhibition and apoptosis (2006) (1)
- A population‐based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival (2020) (1)
- DOSE‐DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH‐RISK DLBCL: A COMPARISON OF NORDIC CRY‐04 AND CHIC STUDIES (2017) (1)
- IgG subclasses on the lymphocyte surface in chronic lymphocytic leukemia (CLL). (1985) (1)
- [Acute abdominal symptoms in patients with granulocytopenia--a clinical dilemma]. (1987) (1)
- Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation Signatures (2020) (1)
- Response to Splenectomy Is Durable after a Certain Point in Time in Adult ITP Patients. (2005) (1)
- Response: More on disease anticipation in familial MPN. (2008) (1)
- Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease. (1982) (1)
- How much chemotherapy in advanced Hodgkin's disease? (1997) (1)
- Chronic myeloid leukemia presenting late in pregnancy. Report of a case and a questionnaire reflecting diversity in management options (2009) (1)
- Reply to D. Pulte et al. (2017) (1)
- Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis (2018) (1)
- Eighteen Years Experience of Granulocyte Donations - Acceptable Donor Safety? (2014) (1)
- Genetic and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia (2009) (1)
- Biology of vascular disease (1987) (1)
- Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls (2021) (1)
- Mo1035 - Iron-Deficiency Anemia and Prevalence of Celiac Disease - A Systematic Review with Meta-Analysis (2018) (1)
- Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases (2019) (1)
- Lymphocyte and granulocyte function in nutritionally depleted patients. The effect of 2 weeks of total parenteral nutrition. (1993) (1)
- Sick Leave due to Depressive Disease: Not a Risk Factor for the Development of Malignant Lymphoma (2005) (1)
- Influence of thymectomy, transfer of thymus and bone marrow cells and treatment with thymosin on the depressed splenic release of lymphocytes into the blood after irradiation. (2009) (1)
- High Socioeconomic Status (SES) Is Associated with Superior Survival in Patients with Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM). A Population-Based Study. (2007) (1)
- AML-176: Characteristics, Treatment Patterns and Predictors of Outcomes in Treatment-Naive Acute Myeloid Leukemia Patients Judged Ineligible for Intensive Chemotherapy in Sweden (2021) (0)
- Levamisole (LMS) in hodgkin's disease (HD) (1980) (0)
- Family History of Venous Thromboembolism As a Risk Factor for Thrombosis in Multiple Myeloma Patients: A Population-Based Study, (2011) (0)
- Human 15-lipoxygenase-1 is a regulator of dendritic-cell spreading and podosome formation Human 15-lipoxygenase-1 is a regulator of dendritic-cell spreading and podosome formation. (2016) (0)
- P076: Pneumococcal infection in splenectomised Hodgkin lymphoma patients: Do they pose a problem today and what is the best long-term strategy? (2022) (0)
- University of Southern Denmark Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis Leppä, (2020) (0)
- ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells (2019) (0)
- immune- r elated and i nflammatory c onditions and r isk of l ymphoplasmacytic l ymphoma or Waldenström Macroglobulinemia (2010) (0)
- CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18- 64 Years (2008) (0)
- YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA INCLUDING BCL‐2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE‐DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS (2019) (0)
- undetermined significance in Sweden first-degree relatives of 4458 patients with monoclonal gammopathy of Risk of plasma cell and lymphoproliferative disorders among 14621 (2013) (0)
- Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre‐ibrutinib era: A population‐based study (2021) (0)
- Re: Risk of malignancy associated with Lyme disease: Still up in the air (2012) (0)
- Impact Of History Of Autoimmune Disease On Survival In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance: A Population-Based Study (2013) (0)
- Use of exon-based transcriptome profiling to identify novel signaling pathways and survival-associated genes in diffuse large B-cell lymphoma. (2012) (0)
- [Invasive aspergillosis--infectious complications in the granulocytopenic patient]. (1982) (0)
- Acute Lymphoblastic Leukaemia in Adult Patients HELENE HALLBÖÖK Studies of Prognostic Factors , Treatment Results and in vitro Cellular Drug Resistance (2005) (0)
- Improved Prognosis in Multiple Myeloma-a Population Based Study on 13,376 Patients Diagnosed in Sweden 1973–2001. (2004) (0)
- Healthcare Resource Utilization and Sickness Absence in Newly Diagnosed Multiple Myeloma Patients in Sweden: Trends in a Changing Treatment Landscape (2020) (0)
- [HTLV-1 induced adult T-cell leukemia. The first case now documented in Sweden]. (1999) (0)
- Absolute and Relative Blood Lymphocyte Subset Counts before and during Treatment of Patients with Thrombotic Thrombocytopenic Purpura (TTP). (2006) (0)
- PF641 CHARACTERIZATION OF TREATMENTS AND REAL-LIFE OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WHO RECEIVED FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION IN SWEDEN (2019) (0)
- Novel Findings Support a Patophysiological Role of the Arachidonic Cascade in Hodgkin Lymphoma. (2007) (0)
- A simple method for electronic counting of rosette forming human blood lymphocytes. (1985) (0)
- Survival from Acute Lymphoblastic Leukemia (ALL) in Adult Patients in the United States and Sweden : Evidence of Recent Improvement (2014) (0)
- Arterial blood oxygenation, maximum exercise capacity and oxygen transport in patients before and after autologous peripheral blood progenitor cell transplantation (1999) (0)
- [Acute pulmonary embolism]. (1980) (0)
- Multiple myeloma and comorbidity: a population-based study (2019) (0)
- Patterns of Expression of CD15, CD33, CD34 and HLA-DR Predict Prognosis in Patients with AML. (2004) (0)
- Individualized Multidrug Resistance In Acute Myeloid Leukemia (2010) (0)
- of maturation arrest and the relation to clinical findings antibodies and immunoglobulin secretion studies: identification of stages Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal (2011) (0)
- Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study (2010) (0)
- leukemias of B-cell lineage Cyclin E overexpression in relapsed adult acute lymphoblastic (2011) (0)
- Reproductive history, as measured by parity, age at first birth and sex of offspring, and cancer-specific survival after a haematological malignancy (2022) (0)
- Patterns of Venous Thromboembolism (VTE) Following Monoclonal Gammopathy of Undetermined Significance (MGUS) and Multiple Myeloma (MM) among 4 Million U.S. Veterans. (2006) (0)
- Therapeutic Effects of Low-Dose Cytosine Arabinoside, α-Interferon, 1,25-Dihydroxyvitamin D3 and Retinoic Acid in Myelodysplastic Syndromes and Acute Leukemia (1987) (0)
- Healthcare resource utilisation and sickness absence in newly diagnosed multiple myeloma patients who did not undergo autologous stem cell transplantation: Trends in Sweden with the changing treatment landscape (2021) (0)
- METABOLIC TUMOR IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PATIENTS TREATED BY R ‐ CHOP – FROM REMARC, A LYSA STUDY (2021) (0)
- Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases (2018) (0)
- GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma (2022) (0)
- Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37]. (2017) (0)
- Bacteremia In Hospitalized Patients with Malignant Blood Disorders: a Retrospective Comparative Study of Causative Agents and Antimicrobial Susceptibility Profiles (2010) (0)
- Lymphoma Group randomized trial while outcome is unaffected by filgrastim treatment: results of a Nordic CHOP is superior to CNOP in elderly patients with aggressive lymphoma (2013) (0)
- The telomerase gene polymorphisms, but not telomere length, increase susceptibility to primary glomerulonephritis/end stage renal diseases in females (2020) (0)
- [Varicose veins--classification and treatment]. (1980) (0)
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Commentary (2008) (0)
- No evidence of enterohepatic circulation of doxorubicin in a patient with transitory biliary obstruction due to lymphoblastic lymphoma. (1991) (0)
- [Klippel-Trénaunay-Weber syndrome (KTWS)--clinical classification of pathophysiologically separate diseases]. (1977) (0)
- Brief report Infection in infancy and subsequent risk of developing lymphoma in children and young adults (2011) (0)
- Arachidonic Acid Metabolism-Related Molecules as Candidate Markers in Subclassification of Lymphoma (2008) (0)
- study of 9,729 patients diagnosed in Sweden 1973-2005 Improved patient survival for acute myeloid leukemia: A population-based (2013) (0)
- Serum cytokine pattern in neutropenic patients during start of fever – clinical implications (1995) (0)
- Multiple Myeloma Patients With Prior Knowledge Of MGUS Have a Better Survival Compared To Multiple Myeloma Patients Without Prior Knowledge Of MGUS (2013) (0)
- International Society of Haematology(European and African Division) XIV meeting, 30 August-4 September 1997, Stockolm, Sweden : education programme (1997) (0)
- STUDIES ON THE REGULATION AND FUNCTION OF LIPOXYGENASES IN HODGKIN LYMPHOMA (2014) (0)
- [Autoimmune hemolytic anemia as an unusual complication of sarcoidosis]. (1985) (0)
- Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors (2017) (0)
- [Risk of transfusion-associated non-A, non-B hepatitis in the treatment of hematologic malignancy]. (1990) (0)
- Book review of “A history of hematology: from Herodotus to HIV”, Shaun R. McCann, Oxford Medical Histories (2016) (0)
- Patterns of Childbirth in Women with Myeloproliferative Neoplasms (2022) (0)
- Lymphoma biology 373 B-CELL LYMPHOMA CELLS OVEREXPRESSING BMI-1 ARE CORRELATED WITH DRUG RESISTANCE THROUGH ENHANCED EXPRESSION OF SURVIVIN AND ARE MORE EFFECTIVELY ELIMINATED BY T CELLS WITH CHIMERIC RECEPTOR AGAINST CD 38 THAN CD 19 (2011) (0)
- Plasma Affinity Proteomic Immunoprofiling As a Novel Prognostic Tool in High Risk Diffuse Large B-Cell Lymphoma Patients: A Nordic Lymphoma Group Study (2014) (0)
- Outpatient parenteral antibiotic therapy (OPAT) in patients with acute leukaemia (AL) and aggressive non-Hodgkin's lymphoma (NHL) (1999) (0)
- Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study. (2009) (0)
- Leukotrienes Stimulate the Release of Cytokines and Proliferation of Hodgkin Reed-Sternberg Cells. (2006) (0)
- G-CSF Supported CHOP-14 with Rituximab in Patients <60 Years with High-Risk Diffuse Large B Cell Lymphoma (DLBCL). (2005) (0)
- The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study (2018) (0)
- Erratum (2011) (0)
- Serum Proteome Profiling Reveals Inflammatory, Molecular and Prognostic Information Beyond the Ctdna in Aggressive B-Cell Lymphomas (2022) (0)
- Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls (2020) (0)
- Long Term Efficacy And Tolerability Of Anagrelide In Myeloproliferative Disorders (2008) (0)
- [How much can it cost?]. (1992) (0)
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma (2008) (0)
- Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005, (2011) (0)
- Antibody Response to Pneumococcal Polysaccharide Vaccination Predicts Pneumococcal Disease in Splenectomized Patients with Hematological Diseases. (2004) (0)
- Prospective comparison of fine-needle aspiration cytology (FNAC) and histopathology in the diagnosis and subclassification of primary lymphomas (2000) (0)
- Monoclonal Gammopathy of Undetermined Significance and Risk of Infections A Population Based Study (2010) (0)
- Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population‐based study (2019) (0)
- REAL WORLD DATA ON CHRONIC MYELOID LEUKEMIA - A REPORT FROM THE SWEDISH POPULATION BASED CML-REGISTRY in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 95, issue , pp 337-338 (2010) (0)
- Fludarabine for the Treatment of Advanced Chronic Lymphocytic Leukemia: Results of a Prospective Randomized Comparison with Cyclophosphamide, Doxorubicin and Prednisone (1997) (0)
- MSR132 Integrating Relative Survival Framework for Survival Extrapolation in Multi-State Models—An Application to Predicting Quality-Adjusted Life Years for Chronic Myeloid Leukemia Patients (2022) (0)
- Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin’s lymphoma—a 20-year follow-up (2006) (0)
- [A subcutaneously implantable catheter in hematologic malignancy--a comparison with a conventional central venous catheter]. (1988) (0)
- Abstract 582: hTERT inhibition stimulates cyclooxygenase2 (COX2) expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects. (2013) (0)
- Abstract 3109: The TERT variant rs2736100_AC is associated with reduced risk of upper track urothelial carcinomas (2016) (0)
- Clinical features of Hodgkin's disease in Cuba and Sweden. (1989) (0)
- No excess risk for malignant lymphomas after sick leave due to psychiatric disease A Swedish cohort Study (2003) (0)
- Incidence and Risk Factors for Central Nervous System Manifestation in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma. (2005) (0)
- Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden (2016) (0)
- Induction treatment with alpha-interferon in multiple myeloma: an interim report from MGCS. (1989) (0)
- Anemia and celiac disease 1 Prevalence of Celiac Disease in Patients with Iron Deficiency Anemia – a Systematic Review with Meta-analysis (2018) (0)
- No Increased Prevalence of Malignancies Among First-Degree Relatives of Patients with Chronic Myeloid Leukemia - Data from Population-Based Swedish Registries (2016) (0)
- [Multiple myeloma--pathophysiology and treatment]. (1988) (0)
- Cost-Utility Analysis of Posaconazole Versus Fluconazole for Prevention of Invasive Fungal Infections in Patients with Graft-Versus-Host Disease in Sweden (2013) (0)
- Abstract 3816: The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression (2015) (0)
- [The man behind the syndrome: Thomas Hodgkin. An impulsive pioneer of pathology and fighter for justice for the poor]. (1983) (0)
- Patterns of expression of CD33, CD15, CD34 and HLA-DR identify groups of AML patients with various prognosis (2004) (0)
- Virus Reactivation Profile as Assessed by PCR and Serology Pattern Following First-Line Alemtuzumab (Anti-CD52 Monoclonal Antibody, Campath®) Therapy in Patients with B-CLL. (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Magnus Björkholm?
Magnus Björkholm is affiliated with the following schools:
